Beyond conventional immune-checkpoint inhibition—novel immunotherapies for renal cell carcinoma
The management of advanced-stage renal cell carcinoma (RCC) has been transformed by
the development of immune-checkpoint inhibitors (ICIs). Nonetheless, most patients do not …
the development of immune-checkpoint inhibitors (ICIs). Nonetheless, most patients do not …
[HTML][HTML] Beyond conventional immune checkpoint inhibition: renal cell carcinoma at the forefront of solid tumor immunology
The management of advanced renal cell carcinoma (RCC) has been transformed by the
development of immune checkpoint inhibitors (ICIs), but still most RCC patients do not …
development of immune checkpoint inhibitors (ICIs), but still most RCC patients do not …
Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors
Introduction Metastatic renal cell carcinoma with sarcomatoid dedifferentiation (sRCC) is
associated with poor survival outcomes. We aimed to analyze the efficacy and safety of …
associated with poor survival outcomes. We aimed to analyze the efficacy and safety of …
9p21 loss defines the evolutionary patterns of aggressive renal cell carcinomas
F Carbone, JK Huang, L Perelli, ED Poggetto… - bioRxiv, 2020 - biorxiv.org
Dedifferentiation and acquisition of chromosomal instability in renal cell carcinoma portends
dismal prognosis and aggressive clinical behavior. However, the absence of reliable …
dismal prognosis and aggressive clinical behavior. However, the absence of reliable …